Science Market Update

Texas A&M Gains Research Funding to Study Post-Traumatic Epilepsy

Posted by Rebecca Partridge on Wed, Oct 26, 2016

Traumatic brain injury, or TBI, is the leading cause of disability among U.S. military personnel and veterans. What’s more, 50% of people with TBI develop spontaneous seizures. If the seizures become recurrent then the condition qualifies as Post-Traumatic Epilepsy, PTE. Now thanks to a 3 year, $750,000 research grant from the Department of Defense and the Army, researchers at Texas A&M will conduct a study on TBI to uncover the molecular and epigenetic mechanism of PTE.

Read More

Tags: Epilepsy, Texas A&M University, Texas, Research Funding, TX, research grant, Southwest Region, new research grant

Top Vet Schools Conduct Millions in NIH-backed Research in 2015

Posted by Robert Larkin on Tue, Jan 19, 2016

Read More

Tags: Michigan State University, Ohio State University, University of Minnesota, UMN, TAMU, MI, TX, MN, OH, Texas A&M, MSU, OhStu, 2016, BioResearch Product Faire™

$650M Expansion to Benefit Memorial Hermann-Texas Medical Center

Posted by Robert Larkin on Tue, Dec 08, 2015

The Texas Medical Center is growing yet again, amid the imminent renovation and expansion of the Memorial Hermann-Texas Medical Center Campus. (image source: memorialhermann.org)

Read More

Tags: Biomedical expansion, Medical Research, new medical facility, Texas Medical Center, Texas, Research Funding, TX, Southwest Region, new Building, research facilities, new medical buildings, 2016, BioResearch Product Faire™, Memorial Hermann

$1.5M Granted to TAMU Researcher from U.S. Dept. of Energy

Posted by Robert Larkin on Tue, Dec 01, 2015

Carbon emissions may be at an all time high, but thanks to research currently being conducted at Texas A&M University (TAMU), clearer skies may be in our future.

Read More

Tags: Texas A&M University, Southwest, Southwest life science marketing events, energy research, College Station, TAMU, BioResearch Product Faire Event, TX, 2016

Houston Researchers Identify Genes Involved in Rare Sézary Syndrome

Posted by Laura Braden on Mon, Nov 16, 2015

Sézary syndrome is a rare form of T-cell lymphoma that causes different types of lesions to appear on the skin once. Very little is known about the cause of this cancer, and there are no current cures available. Researchers from Baylor College of Medicine and the MD Anderson Cancer Center in Houston, Texas have identified certain genes that, when mutated, appear to play a role in Sézary syndrome

Read More

Tags: cancer research, Texas Medical Center, Southwest, tmc, BioResearch Product Faire Event, Houston, TX, 2016, Sezary Syndrome

TMC Researchers Test Mushroom Extract to Beat HPV

Posted by Laura Braden on Fri, Jan 16, 2015

Imagine knowing that you have a disease that could potentially lead to cancer, and having to live in a state of constant uncertainty about whether or not a tumor would develop. For people with Human Papillomavirus (HPV), the most common sexually transmitted disease in the United States, this is a reality. HPV is a serious disease that can lead to cervical cancer (along with other types). Although there is now a vaccines for the disease, there is no known cure for those already afflicted. Life science researchers at The University of Texas Health Science Center (UTHealth) in Houston have recently discovered that an extract from shiitake mushrooms could potentially lead to a cure for HPV. 

Read More

Tags: Texas Medical Center, Southwest, 2015, tmc, BioResearch Product Faire Event, Houston, TX, Shiitake Mushrooms, HPV, Active Hexose Correlated Compound, Mushrooms, AHCC

New Vaccine Manufacturing Facility Under Construction at Texas A&M University

Posted by Laura Braden on Wed, Nov 26, 2014

When a pandemic appears in the world, people start to worry about whether or not they will be affected by the disease. Questions arise like: What are the chances of it spreading? Are there vaccines? Pandemics like the H5N1 avian flu in 2004, the H1N1 flu virus in 2009, and most recently the Ebola epidemic in West Africa have brought about these types of questions. Most often, when an epidemic breaks out, there is not a common vaccine or cure right away. Texas A&M University is in the process of designing a new Pandemic Influenza Vaccine Manufacturing Facility expected to be operational in 2017. 

Read More

Tags: Southwest, 2015, College Station, TAMU, BioResearch Product Faire Event, TX, Texas A&M

Houston Research Institutions Awarded $18 Million

Posted by Laura Braden on Mon, Nov 17, 2014

Exxon Mobil, the most traded international oil and gas company in the world, donates millions of dollars annually to community organizations that work with the sciences, health and education. The company, which has headquarters in both Irving and Houston, Texas, has a long history of helping out local Texas organizations. Keeping with its commitment to working in Texas, Exxon Mobil recently announced that it will donate $18 million to three research institutions located within the Texas Medical Center in Houston.                                            

Read More

Tags: Texas Medical Center, Southwest, 2015, tmc, BioResearch Product Faire Event, Houston, TX

BIG Opportunities to Sell Lab Equipment at Texas Life Science Marketing Events

Posted by Laura Braden on Wed, Nov 12, 2014

As the largest state in the continental U.S. and the second most populous state of all 50, it is no wonder that the Lone Star State is known for being BIG. Amongst the big things in Texas are three world-class research institutions: University of Texas Austin, Texas A&M University in College Station, and Texas Medical Center in Houston.

Read More

Tags: University of Texas, Texas Medical Center, Southwest, UTAust, 2015, Austin, College Station, TAMU, tmc, BioResearch Product Faire Event, Houston, TX, Texas A&M

$5.8 Million Awarded to New Collaborative Program to Study Genes to Find New Drug Targets

Posted by Laura Braden on Wed, Nov 05, 2014

There are thousands of genes in the human genome that all have different purposes. At least 3,000 of these genes are known to express proteins that can be altered by different medications, however, the FDA has only approved drugs that target around 10 percent of these genes. That means that there are still thousands of genes that have not been thoroughly studied that, with the help of the right medication, could be targeted to help improve human health. The National Institutes of Health Common Fund has awarded 8 U.S. institutions $5.8 million for a new collaborative three-year program called Illuminating the Druggable Genome (IDG) that will study different genes and their potential to be modified by different medicines. 

Read More

Tags: CA, Mount Sinai School of Medicine, University of California San Francisco, Texas Medical Center, New York, Southwest, 2015, MSSM, tmc, San Francisco, SFVS, BioResearch Product Faire Event, Houston, NY, TX, UC San Francisco, Biotechnology Vendor Showcase Event, North East

Connect With Us   Like Us on Facebook   Follow Us on Twitter   See our latest photos!   Join Us on Google +   Find Us on LinkedIn   Pin our latest stories!

Subscribe to Company News

Subscribe to this blog!